GeneDx Holdings Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
GeneDx Holdings Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • GeneDx Holdings Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$8.31M, a 80.3% increase year-over-year.
  • GeneDx Holdings Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$83.5M, a 81.8% increase year-over-year.
  • GeneDx Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$176M, a 68% increase from 2022.
  • GeneDx Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$549M, a 124% decline from 2021.
  • GeneDx Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$245M, a 1.68% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$83.5M -$8.31M +$34M +80.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 -$117M -$29.2M +$17.5M +37.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 -$135M -$20.2M +$40.8M +66.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 -$176M -$25.8M +$283M +91.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$459M -$42.3M +$35.3M +45.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$494M -$46.7M +$39M +45.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$533M -$61M +$15.9M +20.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 -$549M -$309M -$269M -668% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 -$280M -$77.6M -$110M -337% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$170M -$85.7M -$39.6M -85.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$131M -$76.9M +$115M +59.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$245M -$40.2M +$85.5M +68% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 -$331M $32.7M +$89.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$420M -$46.2M -$14.1M -44% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$406M -$192M -$165M -611% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$241M -$126M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$56.6M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 -$32.1M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 -$27M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.